SHARON COHEN

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 (no bill number yet) Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters Legislation (no bill number yet) regarding private not-for-profit foundations paying for health exchange premiums and cost sharing for certain individuals.

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters HR 3742, Access to Marketplace Insurance Act

HR 2., "Medicare Access and CHIP Reauthorization Act of 2015" S. 810, "SGR Repeal and Medicare Provider Payment Modernization Act of 2015" The Treat and Reduce Obesity Act of 2015 (no bill number yet) -- Medicare coverage of FDA-approved obesity medications In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 S 810 -SGR Repeal and Medicare Provider Payment Modernization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2., "Medicare Access and CHIP Reauthorization Act of 2015" S. 810, "SGR Repeal and Medicare Provider Payment Modernization Act of 2015" The Treat and Reduce Obesity Act of 2015 (no bill number yet) -- Medicare coverage of FDA-approved obesity medications In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets as well as Medicare coverage for FDA-approved obesity medications.

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 S 810 -SGR Repeal and Medicare Provider Payment Modernization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act (no bill number yet), specifically NDPP funding

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters Legislation (no bill number yet) regarding private not-for-profit foundations paying for health exchange premiums and cost sharing for certain individuals.

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters HR 3742, Access to Marketplace Insurance Act

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters HR 3742, Access to Marketplace Insurance Act

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 S 810 -SGR Repeal and Medicare Provider Payment Modernization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 6 - 21st Century Cures Act FDA issues regarding biosimilar products; 340B program matters

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 6 - 21st Century Cures Act FDA issues regarding biosimilar products; 340B program matters

HR 6 - 21st Century Cures Act FDA issues regarding biosimilar products; 340B program matters

Obesity product matters HR 639/S. 481 --Improving Regulatory Transparency for New Medical Therapies Act re: DEA scheduling of controlled substances

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 S 810 -SGR Repeal and Medicare Provider Payment Modernization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act (no bill number yet), specifically NDPP funding

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters Legislation (no bill number yet) regarding private not-for-profit foundations paying for health exchange premiums and cost sharing for certain individuals.

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters HR 3742, Access to Marketplace Insurance Act

Obesity product matters HR 639/S. 481 --Improving Regulatory Transparency for New Medical Therapies Act re: DEA scheduling of controlled substances

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters Legislation (no bill number yet) regarding private not-for-profit foundations paying for health exchange premiums and cost sharing for certain individuals.

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters HR 3742, Access to Marketplace Insurance Act

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 S 1695 / HR 3020 -- National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters

HR 1192/S 586 National Diabetes Clinical Care Commission Act of 2015 National Diabetes Prevention Program funding as part of the Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act for FY 2016 (no bill number yet) Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone, obesity and rare disease matters

HR 2., "Medicare Access and CHIP Reauthorization Act of 2015" S. 810, "SGR Repeal and Medicare Provider Payment Modernization Act of 2015" The Treat and Reduce Obesity Act of 2015 (no bill number yet) -- Medicare coverage of FDA-approved obesity medications In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets as well as Medicare coverage for FDA-approved obesity medications.

HR 2 - Medicare Access and CHIP Reauthorization Act of 2015 S 810 -SGR Repeal and Medicare Provider Payment Modernization Act of 2015 PL 114-10 -- Medicare Access and CHIP Reauthorization Act of 2015 S 1509 / HR 2404-- Treat and Reduce Obesity Act of 2015 -- Medicare coverage of FDA-approved obesity medications HR 6 - 21st Century Cures Act In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

HR 2., "Medicare Access and CHIP Reauthorization Act of 2015" S. 810, "SGR Repeal and Medicare Provider Payment Modernization Act of 2015" The Treat and Reduce Obesity Act of 2015 (no bill number yet) -- Medicare coverage of FDA-approved obesity medications In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets including potential changes to Part D as well as Medicare coverage for FDA-approved obesity medications.

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act (no bill number yet), specifically NDPP funding

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act (no bill number yet), specifically NDPP funding

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. Department of Defense Appropriations Act, 2016 (no bill number yet), specifically DoD/TRICARE coverage of FDA-approved obesity drugs.

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H.Con.Res. 27, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. S 1695 /HR3020 --FY 2016 Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, specifically NDPP funding. HR 2029 the FY 2016 Consolidated Appropriations Act; PL 114-113 HR 3660 Preventive Health Savings Act HR 716/H.J.Res 61 Continuing Appropriation through 12/11/15 (PL114-53).

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 HJ Res 124 Continuing Appropriations Resolution, 2015 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 83 Consolidated and Further Continuing Appropriations Act, 2015, PL 113-235 which include the FY 15 Department of Defense Appropriations Act, 2015, specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 HJ Res 124 Continuing Appropriations Resolution, 2015 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 4870 Department of Defense Appropriations Act, 2015 and the Senate FY 2015 Defense Appropriations Act (no bill number yet), specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet, HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 4870 Department of Defense Appropriations Act, 2015 and the Senate FY 2015 Defense Appropriations Act (no bill number yet), specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yetIn all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yetIn all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 HJ Res 124 Continuing Appropriations Resolution, 2015 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 83 Consolidated and Further Continuing Appropriations Act, 2015, PL 113-235 which include the FY 15 Department of Defense Appropriations Act, 2015, specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets HR 2415/S 1184 - Treat and Reduce Obesity Act of 2013 -- Medicare coverage of obesity medications

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 HJ Res 124 Continuing Appropriations Resolution, 2015 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 4870 Department of Defense Appropriations Act, 2015 and the Senate FY 2015 Defense Appropriations Act (no bill number yet), specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet, HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding HR 83 - Consolidated and Further Continuing Appropriations Act, 2015

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products FY Defense Appropriations Act, specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets HR 2415/S 1184 - Treat and Reduce Obesity Act of 2013 -- Medicare coverage of obesity medications

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets HR 2415/S 1184 - Treat and Reduce Obesity Act of 2013 -- Medicare coverage of obesity medications

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 4870 Department of Defense Appropriations Act, 2015 and the Senate FY 2015 Defense Appropriations Act (no bill number yet), specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 HR 83 - Consolidated and Further Continuing Appropriations Act, 2015 - PL Law No: 113-235 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets HR 2415/S 1184 - Treat and Reduce Obesity Act of 2013 -- Medicare coverage of obesity medications

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet, HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 HJ Res 124 Continuing Appropriations Resolution, 2015 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 83 Consolidated and Further Continuing Appropriations Act, 2015, PL 113-235 which include the FY 15 Department of Defense Appropriations Act, 2015, specifically DoD/TRICARE coverage of obesity drugs

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024 HJ Res 124 Continuing Appropriations Resolution, 2015 In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of obesity Rx products HR 4870 Department of Defense Appropriations Act, 2015 and the Senate FY 2015 Defense Appropriations Act (no bill number yet), specifically DoD/TRICARE coverage of obesity drugs

National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone and rare disease matters HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013 HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013 HR 1915/S 907 - Gestational Diabetes Act of 2013

National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone and rare disease matters HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013 HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013 HR 1915/S 907 - Gestational Diabetes Act of 2013

National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone and rare disease matters HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013 HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013 HR 1915/S 907 - Gestational Diabetes Act of 2013

National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014 Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening Human growth hormone and rare disease matters HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013 HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013 HR 1915/S 907 - Gestational Diabetes Act of 2013